Concepedia

Suzanne Hitchcock‐Bryan

SH

Statistics

Publications

8

Citations

1.1K

H-Index

8

Active since

1981

Affiliations

Dana-Farber Cancer Institute(Current)

Harvard University

Suzanne Hitchcock‐Bryan is an author at Dana-Farber Cancer Institute specializing in oncology, medicine, and acute lymphoblastic leukemia therapy.

Publications per year

1981–2011

8

Publications

8

Four-Agent Induction and Intensive Asparaginase Therapy for Treatment of Childhood Acute Lymphoblastic Leukemia

Luis A. Clavell, Richard D. Gelber, Harvey J. Cohen et al. · New England Journal of Medicine · 1986 · 427 citations

, , +15

Influence of intensive asparaginase in the treatment of childhood non-T-cell acute lymphoblastic leukemia.

SE Sallan, Suzanne Hitchcock‐Bryan, Richard D. Gelber et al. · PubMed · 1983 · 200 citations

, , +16

A Phase I Study of Foretinib, a Multi-Targeted Inhibitor of c-Met and Vascular Endothelial Growth Factor Receptor 2

Joseph P. Eder, Geoffrey I. Shapiro, Leonard J. Appleman et al. · Clinical Cancer Research · 2010 · 193 citations · Full text

, , +17

Efficacy and morbidity of central nervous system "prophylaxis" in childhood acute lymphoblastic leukemia: eight years' experience with cranial irradiation and intrathecal methotrexate

Adlette Inati, SE Sallan, J. Robert Cassady et al. · Blood · 1983 · 102 citations · Full text

, , +17

Comparative analysis of treatment programs for childhood acute lymphoblastic leukemia.

CM Niemeyer, Suzanne Hitchcock‐Bryan, SE Sallan · PubMed · 1985 · 82 citations

, , +9

1–5 of 8